Hony offloads 11% stake in CSPC The private equity firm raises HK$4.095 billion from the sale of 650 million secondary shares in the Chinese pharmaceuticals group. August 28, 2014
Luye Pharma locks in IPO cornerstones The Chinese healthcare company began taking institutional orders on Monday, with the book already multiple times covered. June 23, 2014